Epigenetic regulation of cancer-associated fibroblast heterogeneity
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023-05 · 1878 (3) · 188901
DOI: 10.1016/j.bbcan.2023.188901 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023-05. Verfasst von Rachel J Kehrberg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Neoplasms, MicroRNAs. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, UNIVERSITY OF NEBRASKA MEDICAL CENTER.
Abstract (Originalsprache)
Cancer-associated fibroblasts (CAFs), a significant component of the tumor microenvironment (TME), contribute to cancer progression through the secretion of extracellular matrix (ECM), growth factors, and metabolites. It is now well recognized that CAFs are a heterogenous population with ablation experiments leading to reduced tumor growth and single-cell RNA sequencing demonstrating CAF subgroups. CAFs lack genetic mutations yet substantially differ from their normal stromal precursors. Here, we review epigenetic changes in CAF maturation, focusing on DNA methylation and histone modifications. DNA methylation changes in CAFs have been demonstrated globally, while roles of methylation at specific genes affect tumor growth. Further, loss of CAF histone methylation and gain of histone acetylation has been shown to promote CAF activation and tumor promotion. Many CAF activating factors, such as transforming growth factor β (TGFβ), lead to these epigenetic changes. MicroRNAs (miRNAs) serve as targets and orchestrators of epigenetic modifications that influence gene expression. Bromodomain and extra-terminal domain (BET), an epigenetic reader, recognizes histone acetylation and activates the transcription of genes leading to the pro-tumor phenotype of CAFs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address:…
Förderung
- NCI NIH HHS
- National Institutes of Health
- UNIVERSITY OF NEBRASKA MEDICAL CENTER
Zitieren
APA
Kehrberg, R. J., Bhyravbhatla, N., Batra, S. K., & Kumar, S. (2023). Epigenetic regulation of cancer-associated fibroblast heterogeneity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(3), 188901. https://doi.org/10.1016/j.bbcan.2023.188901
Vancouver
Kehrberg RJ, Bhyravbhatla N, Batra SK, Kumar S. Epigenetic regulation of cancer-associated fibroblast heterogeneity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(3):188901. doi:10.1016/j.bbcan.2023.188901
BibTeX
@article{Kehrberg2023,
author = {Kehrberg, Rachel J and Bhyravbhatla, Namita and Batra, Surinder K and Kumar, Sushil},
title = {Epigenetic regulation of cancer-associated fibroblast heterogeneity},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
volume = {1878},
number = {3},
pages = {188901},
doi = {10.1016/j.bbcan.2023.188901}
}
EUVIMED